$482 Million is the total value of Medicxi Ventures Management (Jersey) Ltd's 14 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $194,442,000 | +8.6% | 39,926,314 | +100.0% | 40.37% | -16.8% |
| Buy | AURA BIOSCIENCES INC | $86,150,000 | +28.8% | 6,079,784 | +100.0% | 17.89% | -1.3% | |
| PCVX | Buy | VAXCYTE INC | $82,142,000 | +80.2% | 3,774,956 | +100.0% | 17.06% | +38.1% |
| MRUS | Buy | MERUS N V | $72,448,000 | +71.3% | 3,200,000 | +100.0% | 15.04% | +31.3% |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $41,368,000 | +47.0% | 4,901,358 | +137.0% | 8.59% | +12.7% |
| OBSV | Buy | OBSEVA SA | $5,056,000 | +113.2% | 3,140,000 | +100.0% | 1.05% | +63.6% |
| CMPI | Sell | CHECKMATE PHARMACEUTICALS IN | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Francesco De Rubertis #1
- Francesco De Rubertis #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PHATHOM PHARMACEUTICALS INC | 16 | Q3 2023 | 69.8% |
| MERUS N V | 16 | Q3 2023 | 25.3% |
| VAXCYTE INC | 14 | Q3 2023 | 44.5% |
| OBSEVA SA | 12 | Q3 2022 | 5.7% |
| CENTESSA PHARMACEUTICALS PLC | 10 | Q3 2023 | 71.3% |
| AURA BIOSCIENCES INC | 8 | Q3 2023 | 22.9% |
| CHECKMATE PHARMACEUTICALS IN | 8 | Q2 2022 | 12.7% |
| NEWAMSTERDAM PHARMA COMPANY | 4 | Q3 2023 | 11.4% |
| SYNTHORX INC | 1 | Q4 2019 | 43.1% |
View Medicxi Ventures Management (Jersey) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-15 |
| 13F-HR | 2024-02-01 |
| 3 | 2024-01-26 |
| 13F-HR | 2023-10-18 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-25 |
| 13F-HR/A | 2022-08-03 |
| 13F-HR | 2022-08-03 |
View Medicxi Ventures Management (Jersey) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.